News & Updates
Filter by Specialty:
Antiviral monoclonal antibody therapies may prevent hospitalization in nonsevere COVID-19
The antiviral monoclonal antibodies casirivimab-imdevimab appear to reduce the risk of hospitalization in patients with nonsevere COVID-19, as do bamlanivimab, bamlanivimab-etesevimab, and sotrovimab, according to the results of a systematic review and meta-analysis.
Antiviral monoclonal antibody therapies may prevent hospitalization in nonsevere COVID-19
08 Oct 2021
Long-term KEEPsAKE data show sustained improvements with risankizumab for PsA
The humanized immunoglobulin G1 monoclonal antibody risankizumab conferred long-term benefit for individuals with active psoriatic arthritis (PsA) who had inadequate responses to biologic and conventional synthetic DMARDs* (csDMARDs), according to the open-label extension (OLE) phase findings of the KEEPsAKE 1 and 2 trials presented at EADV 2021.
Long-term KEEPsAKE data show sustained improvements with risankizumab for PsA
08 Oct 2021
Neurovascular bundle sparing boosts postoperative sexual function in prostate cancer patients
The width of the spared neurovascular bundle (NVB) is an important indicator of postoperative sexual function after robot-assisted laparoscopic prostatectomy for prostate cancer, a recent study has found. These findings point to NVB as an easy intraoperative marker for assessing postoperative outcomes.
Neurovascular bundle sparing boosts postoperative sexual function in prostate cancer patients
08 Oct 2021
Depression and suicidal ideation high in Hong Kong doctors
A cross-sectional study in Hong Kong finds high prevalence of depressive symptoms and suicidal ideation among doctors in Hong Kong, although many remain undiagnosed of depression.
